Shionogi gets Japanese approval for oral COVID treatment
The Japanese company secures emergency approval for its oral COVID-19 treatment in Japan.
Archives for November 28, 2022
Kyowa Kirin divests mature brands to Grünenthal
The two companies will initially form a joint venture collaboration to market the products, before Grünenthal assumes full control.
Novartis plans to take malaria treatment through to P3 trials
Both Novartis and Medicines for Malaria Venture will progress an optimized version of lumefantrine into late-stage trials.